SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2

Related articles

1. Bidirectional Upregulation of Klotho by Triiodothyronine and Baicalein: Mitigating Chronic Kidney Disease and Associated Complications in Aged BALB/c Mice

   This article has 4 authors:

   1. Saswat Kumar Mohanty
   2. Vikas Kumar Sahu
   3. Bhanu Pratap Singh
   4. Kitlangki Suchiang

2. Artesunate Alleviate Kidney Fibrosis by Restoring Klotho Protein and Suppressing Wnt/β-Catenin Signalling Pathway

   This article has 7 authors:

   1. Goran H Mohammad
   2. Julius Kieswich
   3. Abhishek Kumar
   4. Kieran McCafferty
   5. Ramyangshu Chakraborty
   6. Christoph Thiemermann
   7. Magdi M Yaqoob

3. Sirtuin 1 modulation unlocks the therapeutic potential of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in calcific aortic valve stenosis

   This article has 19 authors:

   1. Vincenza Valerio
   2. Ilaria Massaiu
   3. Matteo Franchi
   4. Antoine Rimbert
   5. Zoé Begué-Racapé
   6. Mattia Chiesa
   7. Veronika A. Myasoedova
   8. Valentina Rusconi
   9. Francesca Bertolini
   10. Donato De Giorgi
   11. Alice Bonomi
   12. Sergio Pirola
   13. Marco Zanobini
   14. Paola Di Pietro
   15. Albino Carrizzo
   16. Michele Ciccarelli
   17. Romain Capoulade
   18. Stefano Genovese
   19. Paolo Poggio